Drug
Fondaparinux clinical trials
Also written Arixtra and GSK576428.
- studies test it
- 46
- open now
- 1
- in phase 3
- 16
- first study started
- 2001
Keep track of what changes. Save the Fondaparinux studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
45 studies that test it; most in 2007 (13)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 6 |
| 2007 | 13 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 8
- Phase 3
- 16
- Phase 4
- 10
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 34
GlaxoSmithKline (10) · Duke University (2) · University of Alabama at Birmingham (2) · National Medical Research Center for Therapy and Preventive Medicine (1) · Alliance Foundation Trials, LLC. (1) · National University of Malaysia (1) · University of Milan (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Enoxaparin (5) · Rivaroxaban (2) · Apixaban (2) · Warfarin (2) · Dalteparin (2) · Nadroparin (2) · Edoxaban (1) · Dabigatran (1)
Studies
Open first, then newest update. How each study uses Fondaparinux is read from its arms, and is right about nine times in ten.
Testing it · 46
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingPhase 3Queen Mary University of LondonNCT06370273Written as Fondaparinux Injectable Product
- Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous VeinCompletedPhase 4National Medical Research Center for Therapy and Preventive MedicineNCT05001776Written as Fondaparinux Sodium
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNot applicableAlliance Foundation Trials, LLC.NCT02744092Written as Fondaparinux
- A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNot applicablePrairie Education and Research CooperativeNCT00789399Written as Fondaparinux
- Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU PatientsTerminatedPhase 3Eastern Virginia Medical SchoolNCT00493896Written as Fondaparinux
- Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNot applicableLehigh Valley HospitalNCT00521885Written as Arixtra (Fondaparinox) 2.5 mg SC Daily
- Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With ThrombocytopeniaTerminatedPhase 4G. d'Annunzio UniversityNCT01727401Written as Fondaparinux
- Safety of Fondaparinux as Post Partum ThromboprophylaxisCompletedPhase 4National University of MalaysiaNCT04447378Written as Fondaparinux 2.5Mg/0.5Ml Inj Syr
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedPhase 2University of MilanNCT04368377Written as Fondaparinux
- Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)TerminatedPhase 2University of LouisvilleNCT00673439Written as fondaparinux
- Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)WithdrawnPhase 4Methodist HealthcareNCT00603824Written as fondaparinux
- Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical PatientsCompletedEarly Phase 1Johns Hopkins UniversityNCT00894283Written as Fondaparinux
- Hip Fracture Study of GSK576428 (Fondaparinux Sodium)CompletedPhase 3GlaxoSmithKlineNCT00320424Written as Fondaparinux
- Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)CompletedPhase 3GlaxoSmithKlineNCT00320398Written as Fondaparinux
- Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedPhase 2Masonic Cancer Center, University of MinnesotaNCT00381888Written as fondaparinux sodium
- The Effects of Arixtra on Wound Drainage Following Total Joint ArthroplastyCompletedPhase 4Paul Di Cesare,MDNCT00909064Written as Fondaparinux Sodium (Arixtra)
- Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.TerminatedNot applicableMelbourne HealthNCT00256100Written as Fondaparinux Sodium
- Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic MalignancyTerminatedPhase 3University of Alabama at BirminghamNCT00539942Written as Arixtra (fondaparinux sodium)
- The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedPhase 3GlaxoSmithKlineNCT00981409Written as Fondaparinux sodium
- The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedPhase 3GlaxoSmithKlineNCT00911157Written as Fondaparinux sodium
See all 46 studies that test Fondaparinux →
Given in every arm · 1 — Fondaparinux is usual care beside what is tested
As the comparator · 4 — what is tested is compared with Fondaparinux
- Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial InfarctionRecruitingPhase 4University of AarhusNCT06710184Written as Fondaparinux Sodium
- Hip Fracture Surgery Arterial and Venous Thrombotic Events PreventionNot yet recruitingPhase 3McMaster UniversityNCT07228663Written as Fondaparinux
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus FondaparinuxCompletedPhase 3GWT-TUD GmbHNCT01499953Written as Fondaparinux
- Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT01857583Written as Fondaparinux
Codes
What other systems call Fondaparinux · ClinicalTrials.gg INT006722
- MeSH (NLM) D000077425FondaparinuxConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) J177FOW5JLFONDAPARINUXConfirmed NLM, Wikidata
- RxNorm 321208Confirmed FDA, Wikidata
- Wikidata Q27077698fondaparinuxConfirmed NLM, Wikidata
- NCI Thesaurus C73142FondaparinuxOne source FDA
- DrugBank DB00569One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077425 | Fondaparinux | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | J177FOW5JL | FONDAPARINUX | Confirmed NLM, Wikidata |
| RxNorm | 321208 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27077698 | fondaparinux | Confirmed NLM, Wikidata |
| NCI Thesaurus | C73142 | Fondaparinux | One source FDA |
| DrugBank | DB00569 | — | One source Wikidata |
Also registered as fondaparinux sodium (UNII X0Q6N9USOZ · RxNorm 322154).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.